Stock screenerAll disclosures →
EDGAR →
GMED
Conviction 34HealthcareScan · Tue, Sep 8, 2026GMED$75.04-4.15%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 1.11M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price75.04
Change-4.15%
Gap-1.14%
Rel volume1.83×
Avg volume1.15M
Avg $ vol94.89M
SMA 2083.24
SMA 5080.76
SMA 20085.85
Price vs 50-7.08%
Price vs 200-12.59%
MA stackbearish
50/200 cross—
Supertrenddown · 84.12
RSI (14)31
MACD hist-1.12
MACD crossbear · 9d
Stoch %K / %D1 / 4
ADX (14)18
+DI / −DI13 / 30
RSI divergence—
MACD divergenceBearish
ATR %+3.45%
ADR %2.69%
52w high96.82
52w low55.10
From 52w high-22.50%
Above 52w low+36.19%
New 52w highNo
SqueezeOff
Bollinger width15.94%
%B-0.12
Donchian pos0.65%
Donchian high88.89
Donchian low74.95
AVWAP (52w high)84.51
vs AVWAP high-11.21%
AVWAP (52w low)82.06
vs AVWAP low-8.55%
OBV trendDown
Chaikin MF (20)-0.17
Today vs 20d1.83×
Avg vol (14d)1.11M
Avg vol (20d)1.15M
Avg $ vol (20d)94.89M
Market cap10.08B
RS 3m (vs SPY)-6.56%
RS 6m (vs SPY)-24.66%
RS line new highNo
Trend template3/8
Technical rank14.5
1 week-7.78%
1 month-8.88%
3 months-4.16%
6 months-14.54%
1 year+23.83%
YTD-14.04%
P/E18.73
P/B2.11
P/S3.43
P/FCF17.11
EPS3.92
Div yield—
ROE11.28%
ROA9.80%
Debt/Eq—
Current4.62
EV/EBITDA12.64
Gross margin34.72%
Net margin18.30%
Rev growth16.65%
EPS growth422.28%
Price target102.55
Target upside36.66%
Analyst ratingBuy
Institutional126.45%
Ent. value9.57B
Revenue789.61M
Net income151.57M
Gross profit369.65M
Free cash flow588.77M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out—
Employees6K
ListedFri, Aug 3, 2012
Free float132.06M
Float %97.6%
Short interest6.8M
Days to cover4.0d
Short volume67.4%
Squeeze score61 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.34 vs $1.12
Last surprise+19.6% beat
Setup gradeD
Conviction34 / 100
Pattern quality—
Tech rank14.5 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance88.51
Support75.83
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GMED · 4 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Lisa McClain house · R · MI · traded 2025-06-24 | Sell | $1K–$15K | 2025-06-24 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-07-10 | Sell | $1K–$15K | 2025-07-10 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Buy | $1K–$15K | 2025-06-17 | 2025-08-13 | |
Josh Gottheimer house · D · NJ · traded 2025-04-09 | Sell | $1K–$15K | 2025-04-09 | 2025-05-14 |
Insider activity
SEC Form 4 transactions in GMED · 3 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
ZARRILLI STEPHEN T Director · Class A Common Stock · 2026-08-18 | Exercise | 25K | $1.3M | 2026-08-18 | 2026-08-19 |
ZARRILLI STEPHEN T Director · Stock Option (Right to Buy Class A Common Stock) · 2026-08-18 | Exercise | 25K | — | 2026-08-18 | 2026-08-19 |
ZARRILLI STEPHEN T Director · Class A Common Stock · 2026-08-18 | Sell | 25K | $2.2M | 2026-08-18 | 2026-08-19 |
Davidar David D Director · Class A Common Stock · 2026-07-27 | Gift | 2.5K | — | 2026-07-27 | 2026-07-28 |
Davidar David D Director · Stock Option (Right to Buy Class A Common Stock) · 2026-06-05 | Exercise | 25K | $0 | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Sell | 25K | $2.0M | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Exercise | 25K | $657K | 2026-06-05 | 2026-06-09 |
RHOADS ANN D Director · Class A Common Stock · 2026-06-04 | Exercise | 25K | $657K | 2026-06-04 | 2026-06-08 |
RHOADS ANN D Director · Stock Option (Right to Buy Class A Common Stock) · 2026-06-04 | Exercise | 25K | $0 | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in GMED · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.